For this reason, GPCRs have been a focus of drug development for decades due to their role in regulating Conventional GPCR drug discovery has largely focused on orthosteric sites, but recent breakthroughs in discovery. Over the past decade, there has been a notable growth in the discovery of allosteric modulators for GPCRs Allosteric modulation is gaining prominence in GPCR therapeutics, with the discovery of an intracellular

GPCRs pose a critical challenge in drug discovery: a vast therapeutic potential with many targets yet to be explored.  35% of FDA-approved drugs target GPCRs, showing their importance in numerous physiological However, over half of non-sensory GPCRs do not have drugs available in the clinic, opening the door to What are the current trends in G protein-coupled receptor targeted drug discovery? Expert Opin Drug Discov. 2023 Jul-Dec;18(8):815-820. doi: 10.1080/17460441.2023.2216014.

discovery pipeline. Why Faster, Smarter Decisions Require More Than Kd In drug discovery today, the clock is always ticking Yet most discovery teams still rely on classic affinity metrics alone, often overlooking how kinetic discovery. You’ll gain clarity that accelerates your path from discovery to clinic: Know when your assays truly

Drug discovery and development: Role of basic biological research. discovery. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery. Biased signalling and allosteric machines: new vistas and challenges for drug discovery. Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery.

Targeted Drug Discovery Summit, Boston. fundamentals while keeping pace with modern GPCR research and drug discovery. discovery program. GPCR Podcast—GPCR Assay Strategy, Bias, and Translational Drug Discovery In this episode of the Dr. GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

This Week’s Highlights: Harnessing Deep Mutational Scanning for Enhanced Drug Discovery Cam Sinh Lu Discovery- with Aikium's Dr Venkatesh Mysore Trevena teeters in dangerous territory, terminating CEO Forum Conference November 26 - 28, 2024 | GPCRs-Targeted Drug Discovery Summit Europe December 10 - Drug Discovery February 15 - 19, 2025 | BPS 2025 February 16 - 21, 2025 | Harnessing the Power of Advanced Multimodal Approaches to GPCR Drug Discovery March 12 - 14, 2025 | NextGen Biomed 2025 March 25 - 28

Molecular innovation This Week’s GPCR Intelligence: The next edge in discovery isn’t louder exposure—it Your Membership Gives You: Proven frameworks used in real discovery programs On-demand lessons built Watch our new trailers for a preview of expert-led GPCR training designed for scientists and drug hunters It’s an operating system for discovery decisions, featuring practical frameworks, trusted curations, GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

2026 GPCR Pharmacology AMA: Receptor Theory, Biased Signaling & Assay Interpretation The first GPCR Pharmacology Kenakin will address receptor theory, assay interpretation, biased signaling, and practical drug discovery as new videos are released: ▶️ https://www.youtube.com/@TerryPharmacologyCorner New White Paper on GPCR : Assess GPCR Biased Signaling of Agonists Using Functional Cell-Based Assays The paper explores: Detection ) Systematic comparison of biased agonists using modern functional assays For scientists working in GPCR

That’s not a story about nostalgia — it’s a snapshot of how GPCR research was built, on technique at The field moved from single readouts to integrated signaling landscapes, accelerating drug discovery The GPCR field needs thinkers who can direct platforms, not just operate them. What started as hand-built assays on ice has become integrated platforms for drug discovery, systems GPCR Podcast 🔓 Get tools, deep dives, and exclusive insights with   Dr. GPCR Premium .

What emerged wasn’t just another pharmacology group — it became a collaborative engine for GPCR discovery Most GPCR discoveries aren’t blocked by science — they’re blocked by structures that make sharing hard GPCR science thrives in complexity — meaning no single lab or company can do it alone. And for those shaping the next generation of GPCR discovery — from AI integration to next-gen biosensors GPCR Premium  for deep dives, strategic tools, and behind-the-scenes conversations shaping the GPCR field

October 2022 GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches Read more at the source #DrGPCR #GPCR #IndustryNews

A bitter anti-inflammatory drug binds at two distinct sites of a human bitter taste GPCR Lior Peri ,   Innovation And 2025 Milestones Recursion and Exscientia have merged to enhance drug discovery GPCR Classes Drug Discovery February 15 - 19, 2025 | BPS 2025 February 16 - 21, 2025 | Harnessing the Power of Advanced Multimodal Approaches to GPCR Drug Discovery March 12 - 14, 2025 | NextGen Biomed 2025 March 25 - 28 Discovery Chemistry April 24 - 27, 2025 | American Physiology Summit 2025 April 25 - 30, 2025 | AACR

This week, we help you tighten your interpretations and strengthen your decisions at the bench and in discovery Why this matters Receptor distribution shapes incretin hormone drug effects across islets and neural Sparked a Scientific Journey Molecular Creativity in Drug Discovery Why Dr. GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need Aside from his vast experience in drug development, not to mention his extensive publication record,

discuss current trends in GPCR drug discovery. drug discovery. drug discovery. A New Wave of GPCR Drug Discovery GPCRs are considered highly druggable, with GPCR-targeting therapeutics drug discovery.

For discovery teams, this means a shorter exposure can yield longer efficacy windows—opening doors to Kenakin  will get released next month, featuring real questions from discovery scientists tackling enzyme Join Terry’s Corner and get: Frameworks proven in real discovery programs On-demand lessons  designed That’s why discovery teams turn to Terry’s Corner: to build strategies that anticipate these collisions Kenakin with your own enzyme or GPCR interaction puzzles.

discovery pact Aequorin: superior choice for GPCR calcium signalling GPCR: Structural Insights and Role in Drug Discovery Orion Biotechnology has a new website GPCR Events, Meetings, and Webinars November Forum Conference November 26 - 28, 2024 | GPCRs-Targeted Drug Discovery Summit Europe December 10 - Drug Discovery February 15 - 19, 2025 | BPS 2025 February 16 - 21, 2025 | Harnessing the Power of Advanced Multimodal Approaches to GPCR Drug Discovery March 12 - 14, 2025 | NextGen Biomed 2025 March 25 - 28

Eric Trinquet, that moment arrived when his team successfully tracked GPCR internalization in native Just a plate reader, an agonist, and an endogenous GPCR. What started as a chemistry problem has evolved into a discovery platform. GPCR   Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr. GPCR Premium Ecosystem for behind-the-scenes access to GPCR innovators, exclusive deep-dives, and practical

thinking is the enemy of discovery. If you’re building tools or careers in GPCR science, this is your playbook. The pHSense Breakthrough: Two Dimensions of Discovery pHSense wasn’t built in a vacuum—it was born from GPCR   Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr. GPCR Premium Ecosystem  for behind-the-scenes access to GPCR innovators, exclusive deep-dives, and practical

We're zooming back to the future of GPCR discoveries. Discovery and Antibody Innovation: DeciBio Q&A with Sean McClain, Founder & CEO, and Zach Jonasson, Drug Discovery February 15 - 19, 2025 | BPS 2025 February 16 - 21, 2025 | Harnessing the Power of Advanced Multimodal Approaches to GPCR Drug Discovery March 12 - 14, 2025 | NextGen Biomed 2025 March 25 - 28 Discovery Chemistry April 24 - 27, 2025 | American Physiology Summit 2025 April 25 - 30, 2025 | AACR

discovery strategies. GPCR Event Spotlight Discovery on Target’s 19th Annual GPCR-Based Drug Discovery Targeting G Protein-Coupled Register today for the GPCR Drug Discovery Conference and save $200 with discount code “ DRGPCR24 ”. - The value of GPCR cell-based assays in drug discovery September 22, 2024 | Biomolecular Horizons 2024 26 - 28, 2024 | GPCRs-Targeted Drug Discovery Summit Europe July 12 - 17, 2026 | 20th World Congress

December 2021 "30/11/2021 Confo will work together with Regeneron to apply its GPCR drug discovery platform to enable functional antibody discovery. technology platform, which uses conformationally selective VHH antibodies – ConfoBodies® – to stabilize GPCRs protein-coupled receptors) in disease-relevant conformations, will be applied with the goal of enabling the discovery of novel therapeutic antibody drug candidates. " Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR Ecosystem. GPCR Podcast To mark the spotlight, Dr. GPCR  invited Dr. Eric Trinquet  to the Dr. GPCR. GPCR Dr. Its GPCR research tools  support discovery teams and academic labs with precision reagents and validated

translatome via site-selective activation of mTOR GPCR Binders, Drugs, and more Molecular glues as potential heart failure drug following reverse merger with Avrobio Lilly signs $140M upfront partnership with Webinar - The value of GPCR cell-based assays in drug discovery October 2024 | Biologics US 2024 October Biochemistry, Cellular and Mechanistic Pharmacology; Lead Discovery and Optimization NEW Director/Sr Director GPCR Drug Discovery Biologist HIGHLIGHT Principal Scientist, In vitro pharmacology Post-Doctoral

However, in drug discovery projects, perfection can’t be attained soon enough. If only Voltaire were here today to see how drug discovery is being accelerated by new technologies. Several new technologies that are being used to accelerate drug discovery are highlighted in this article receptors (GPCRs) to enable the discovery of agonistic biologics; and automated instrumentation that Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR, it was with a simple goal: to connect people who shared a passion for GPCR science and discovery Capital, CRO partners, and GPCR experts to help teams move faster — from idea to discovery — while reducing Consulting Corner — a place for teams to get tailored scientific and strategic guidance that helps bridge discovery courses will be included in Premium Membership , giving members full access to learning, connection, and discovery while strengthening discovery where it truly happens — in the lab.

drug discovery Nicola J Smith, Lauren T May, and Natasha L Grimsey for their work on Highlights and Binders, Drugs, and more Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Drug Discovery Engine at ENDO 2024 The Promise of Oxytocin: Novel Approaches for Targeting Oxytocin June 4, 2024 | Live Webinar ‘It All Starts With a Protein – Protein Sciences as a Key to Success in Drug Discovery’ June 9 - 14, 2024 | 2024 Phosphorylation and G-Protein Mediated Signaling Networks June 25

ligands Elements of a comprehensive and effective GPCR discovery Master advanced applications: Using with real-time kinetics Discovering new ligands and GPCR behaviors for unique drug profiles   GPCR Event breathe new life into schizophrenia pipeline GPCR Dynamics Reveal Mechanisms for Drug Discovery DMS: Discovery Ecosystem Summit Tectonic Therapeutic Announces Closing of Merger with AVROBIO as well as in drug discovery October 2024 | Biologics US 2024   October 2 - 4, 2024 | 9th GPCRs in Medicinal Chemistry

How a Collaboration Led to a GPCR Imaging Breakthrough JB didn’t set out to contribute to a GPCR imaging It was the start of a scientific partnership with the potential to shift how GPCRs could be visualized Designing Reliable GPCR Imaging Tools for Real Biological Systems Success brought new challenges. This strategy accelerated discovery and reduced noise, helping them understand how each design change The Future of GPCR Imaging Breakthroughs: AI, Multiplex Tools, and In Vivo Discovery Today, JB leads

Drug discovery does not move in fixed conclusions. discovery efforts. Drug Discovery Programs Pharmacologists know the pressure of distinguishing between orthosteric and discovery pipelines Operationalizing Allosteric Signatures Early workflows often rely on rapid “one-way GPCR systems are sensitive and context-dependent.

Hi GPCR Community, If you work on GPCR discovery, you already know: early signals can mislead, and timing Upcoming events:  “Drug Discovery at Superluminal Speeds”; and Discovery on Target 2025—GPCR track you discovery and translational pharmacology. Read the article here ➤ Discovery on Target 2025 – GPCR Speaker Spotlight DOT 2025 (Sept 22–25, Boston GPCR scientists, translational pharmacologists, biotech discovery teams, platform company leaders, and